Infectious Disease Testing Market Size Projected to Reach $60 billion by 2034 | 7%

According to Straits Research, the global infectious disease testing market size was valued at $28 billion in 2025 and is projected to grow from $30 billion in 2026 to $60 billion by 2034 at a CAGR of 7% during the forecast period 2026-2034.

Growing patient awareness about the benefits of personalized medicines is driving the adoption of molecular diagnostics, genomics, and proteomics technologies for infectious disease testing. Diagnostic tests can be used to assess the efficacy of specific therapeutic agents and treatments in patients. They help in determining the optimal dosages for drugs whose therapeutic effects vary widely depending on the patient.  

Inadequate reimbursements impede the market growth; as per the MedPac (Medicare Payment Advisory Commission), medical testing witnessed a 40% decline in reimbursements. In 2012, Medicare revised its reimbursement mechanism for some IVD tests, including infectious diseases and molecular disease tests.

The leading players are heavily investing in R&D activities to develop advanced sequencing testing. For instance, Genapsys introduced ‘Genius’ an I-pad size sequencing platform with the ability to diagnose multiple molecules in a single run. Similarly, Stratos Genomics developed a fourth-generation sequencer based on sequencing by expansion (SBX), further driving the market growth. 

Key Highlights

• By technology, the DNA sequencing & next-generation sequencing (NGS) segment is projected to grow with a remarkable CAGR due to reducing the cost of sequencing. Currently, NGS is recognized as a primary technology disease testing across the globe.
• North America leads the infectious disease testing market

Market Segments

1. By Product & Services
   1. Kits & reagents
   2. Instruments
   3. Software
2. By Technology
   1. Immunodiagnostics
   2. DNA Sequencing & NGS
   3. PCR
3. By End User
   1. Hospitals/Clinical Laboratories
   2. Reference Laboratories
   3. Physician Offices
   4. Academic/Research Institutes